A study of therapeutic angiogenesis in critical limb ischemia using gelatin hydrogel incorporating basic fibroblast growth factor

A study of therapeutic angiogenesis in critical limb ischemia using gelatin hydrogel incorporating basic fibroblast growth factor - Therapeutic angiogenesis by basic fibroblast growth factor

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000002671

Enrollment

Registered

2009-10-26

Start date

2009-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arteriosclerosis obliterans Buerger&#39

Interventions

Muscular injection of gelatin hydrogel incorporating basic fibroblast growth factor

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients diagnosed with arteriosclerosis obliterans or Burger's disease, which had no option for medical or surgical treatment

Exclusion criteria

Exclusion criteria: Hemodialysis Active diabetic retinopathy Active malignancy Current smoker Allergy for gelatin

Design outcomes

Primary

Measure	Time frame
Transcutanous oxygen tension (TcO2) Adverse events Side effects	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026